Neural Expression and Increased Lavage Fluid Levels of Secretoneurin in Seasonal Allergic Rhinitis

American Journal of Respiratory and Critical Care Medicine

Volumn 167, Issue 11, 2003, Pages 1504-1508

  Korsgren, Magnus ^a   Erjefält, Jonas S ^b   Hinterhölzl, Josef ^b   Fischer Colbrie, Reiner ^b   Emanuelsson, Cecilia Ahlström ^b   Andersson, Morgan ^b   Persson, Carl G A ^b   Mackay Sim, Alan ^b   Sundler, Frank ^b   Greiff, Lennart ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Allergic airway inflammation; Eosinophils; Neuropeptides

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; EOSINOPHIL CATIONIC PROTEIN; NEUROPEPTIDE; SECRETONEURIN; TYROSINE 3 MONOOXYGENASE; VASOACTIVE INTESTINAL POLYPEPTIDE; AUTACOID; EOSINOPHIL GRANULE PROTEIN; PLASMA PROTEIN; RIBONUCLEASE; SECRETOGRANIN II;

ADULT; ALLERGIC RHINITIS; ARTICLE; CELL MIGRATION; CLINICAL ARTICLE; DENDRITIC CELL; EOSINOPHIL; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MONOCYTE; NASAL BIOPSY; NOSE MUCUS; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA; CHEMISTRY; HAY FEVER; IMMUNOLOGY; INNERVATION; METABOLISM; NERVE FIBER; NOSE MUCOSA; POLLEN;

ADULT; BLOOD PROTEINS; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILS; HUMANS; INFLAMMATION MEDIATORS; NASAL LAVAGE FLUID; NASAL MUCOSA; NERVE FIBERS; NEUROPEPTIDES; POLLEN; RHINITIS, ALLERGIC, SEASONAL; RIBONUCLEASES; SECRETOGRANIN II;

EID: 0037794409     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200212-1508OC     Document Type: Article

References (42)

1. 2-Macroglobulin and eosinophil cationic protein in the allergic airway mucosa in seasonal allergic rhinitis. Eur Respir J 1999;13: 633-637.
2. Erjefält JS, Greiff L, Andersson M, Mattsson E, Petersen H, Linden M, Ansari T, Jeffery PK, Persson CGA. Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways. Am J Respir Crit Care Med 1999;160:304-312.
3. Baraniuk JN. Sensory, parasympathetic, and sympathetic neural influences in the nasal mucosa. J Allergy Clin Immunol 1992;90:1045-1050.
4. White MV, Kaliner MA. Mediators of allergic rhinitis. J Allergy Clin Immunol 1992;90:699-704.
5. Fajac I, Braunstein G, Ickovic MR, Lacronique J, Frossard N. Selective recruitment of esosinophils by substance P after repeated allergen exposure in allergic rhinitis. Allergy 1995;50:970-975.
6. Sanico AM, Atsuta S, Proud D, Togias A. Plasma extravasation through neuronal stimulation in the human nasal mucosa in the setting of allergic rhinitis. J Appl Physiol 1998;84:537-543.
7. Philip G, Sanico AM, Togias A. Inflammatory cellular influx follows capsaicin nasal challenge. Am J Respir Crit Care Med 1996;153:1222-1229.
8. Barnes PJ. Neurogenic inflammation in the airways. Respir Physiol 2001; 125:145-154.
9. Greiff L, Svensson C, Andersson M, Persson CGA. Effects of topical capsaicin in seasonal allergic rhinitis. Thorax 1995;50:225-229.
10. American Thoracic Society Workshop. Immunobiology of asthma and rhinitis: pathogenic factors and therapeutic options. Am J Respir Crit Care Med 1999;160:1778-1787.
11. Kirchmair R, Hogue-Angeletti R, Gutierrez J, Fischer-Colbrie R, Winkler H. Secretoneurin: a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C). Neuroscience 1993;53:359-365.
12. Wiedermann CJ. Secretoneurin: a functional neuropeptide in health and disease. Peptides 2000;21:1289-1298.
13. Kirchmair R, Marksteiner J, Troger J, Mahata SK, Mahata M, Donnerer J, Amann R, Fischer-Colbrie R, Winkler H, Saria A. Human and rat primary C-fibre afferents store and release secretoneurin, a novel neuropeptide. Eur J Neurosci 1994;6:861-868.
14. Schmid KW, Kunk B, Kirchmair R, Tötsch M, Böcker W, Fischer-Colbrie R. Immunohistochemical detection of secretoneurin, a novel neuropeptide endoproteolytically processed from secretogranin II, in normal human endocrine and neuronal tissues. Histochem J 1995;27:473-481.
15. Dunzendorfer S, Kaser A, Meierhofer C, Tilg H, Wiedermann CJ. Peripheral neuropeptides attract immature and arrest mature blood-derived dendritic cells. J Immunol 2001;166:2167-2172.
16. Reinisch N, Kirchmair R, Kähler CM. Hogue-Angeletti R, Fischer-Colbrie R, Winkler H, Wiedermann CJ. Attraction of human monocytes by the neuropeptide secretoneurin. FEBS Lett 1993;334:41-44.
17. Dunzendorfer S, Schratzberger P, Reinisch N, Kähler CM, Wiedermann CJ. Secretoneurin, a novel neuropeptide, is a potent chemoattractant for human eosinophils. Blood 1998;91:1527-1532.
18. Dunzendorfer S, Meierhofer C, Wiedermann CJ. Signaling in neuropeptide-induced migration of human eosinophils. J Leukoc Biol 1998;64: 828-834.
19. Greiff L, Andersson M, Persson CGA. Nasal secretions/exudations: collection and approaches to analysis. In: Rogers D, Donnelly L, editors. Human airway inflammation: methods in molecular medicine. Vol. 56. Totowa, NJ: Humana Press Inc.; 2001. p. 61-73.
20. Luts A, Uddman R, Alm P, Basterra J, Sundler F. Peptide-containing nerve fibers in human airways: distribution and coexistence pattern. Int Arch Allergy Immunol 1993;101:52-60.
21. Kato A, Kammen-Jolly K, Fischer-Colbrie R, Humpel C, Schrott-Fischer A, Marksteiner J. Co-distribution patterns of chromogranin B-like immunoreactivity with chromogranin A and secretoneurin within the human brainstem. Brain Res 2000;852:444-452.
22. Arvidsson U, Reidl M, Elde R, Meister B. Vesicular acetylcholine transporter (VAChT) protein: a novel and unique marker for cholinergic neurons in the central and peripheral nervous systems. J Comp Neurol 1997;378:454-467.
23. Tramu G, Pillez A, Leonardelli J. An efficient method of antibody elution for the successive or simultaneous location of antigens by immunocytochemistry. J Histochem Cytochem 1978;26:322-324.
24. Uddman R, Luts A, Sundler F. Occurrence and distribution of calcitonin gene-related peptide in the mammalian respiratory tract and middle ear. Cell Tissue Res 1985;241:551-555.
25. Baraniuk JN, Lundgren JD, Goff J, Mullol J, Castellino S, Merida M, Shelhamer JH, Kaliner MA. Calcitonin gene-related peptide in human nasal mucosa. Am J Physiol 1990;258:L81-L88.
26. Baraniuk JN, Lundgren JD, Okayama M, Mullol J, Merida M, Shelhamer JH, Kaliner MA. Vasoactive intestinal peptide in human nasal mucosa. J Clin Invest 1990;86:825-831.
27. Fang S-Y, Shen C-L, Ohyama M. Distribution and quantity of neuroendocrine markers in allergic rhinitis. Acta Otolaryngol 1998;118:398-403.
28. Uddman R, Alumets J, Densert R, Håkanson R, Sundler F. Occurrence and distribution of VIP nerves in the nasal mucosa and tracheobronchial wall. Acta Otolaryngol 1978;86:443-448.
29. Kahler CM, Fischer-Colbrie R. Secretoneurin: a novel link between the nervous and the immune system: conservation of the sequence and functional aspects. Adv Exp Med Biol 2000;482:279-290.
30. Marksteiner J, Mahata SK, Pycha R, Mahata M, Saria A, Fischer-Colbrie R, Winkler H. Distribution of secretoneurin immunoreactivity in the spinal cord and lower brainstem in comparision with that of substance P and calcitonin gene-related peptide. J Comp Neurol 1994;340:243-254.
31. Collins JJ, Wilson K, Fischer-Colbrie R, Papka RE. Distribution and origin of secretoneurin-immunoreactive nerves in the female rat uterus. Neuroscience 2000;95:255-264.
32. Dun NJ, Dun SL, Lin HH, Hwang LL, Saria A, Fischer-Colbrie R. Secretoneurin-like immunoreactivity in rat sympathetic, enteric and sensory ganglia. Brain Res 1997;760:8-16.
33. Mosimann BL, White MV, Hohman RJ, Goldrich MS, Kaulbach HC, Kaliner MA. Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J Allergy Clin Immunol 1993;92:95-104.
34. Neiber K, Baumgarten CR, Rathsack R, Furkert J, Oehme P, Kunkel G. Substance P and beta-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J Allergy Clin Immunol 1992;90:646-652.
35. Bauer JW, Kirchmair R, Egger C, Fischer-Colbrie R. Histamine induces a gene-specific synthesis regulation of secretogranin II but not of chromogranin A and B in chromaffin cells in a calcium-dependent manner. J Biol Chem 1993;268:1586-1589.
36. Laslop A, Tschernitz C. Effects of nerve growth factor on the biosynthesis of chromogranin A and B, secretogranin II an carboxypeptidase H in rat PC12 cells. Neuroscience 1992;49:443-450.
37. Figueroa JM, Mansilla E, Suburo AM. Innervation of nasal turbinate blood vessels in rhinitic and nonrhinitic children. Am J Respir Crit Care Med 1998;157:1959-1966.
38. Fang S-Y, Shen C-L. Neuropeptide innervation and neuroendocrine cells in allergic rhinitis and chronic hypertrophic rhinitis. Clin Exp Allergy 1998;28:228-232.
39. Kähler CM, Kaufmann G, Hogue-Angeletti R, Fischer-Colbrie R, Dunzendorfer S, Reinisch N, Wiedermann CJ. A soluble gradient of the neuropeptide secretoneurin promotes the transendothelial migration of monocytes in vitro. Eur J Pharmacol 1999;365:65-75.
40. Kähler CM, Schratzberger P, Kaufmann G, Hochleitner B, Bechter O, Götsch C, Wöll E, Marschang P, Herold M, Wiedermann CJ. Transendothelial migration of leukocytes and signalling mechanisms in response to the neuropeptide secretoneurin. Regul Pept 2002;105:35-46.
41. Jacoby DB, Costello RM, Fryer AD. Eosinophil recruitment to the airway nerves. J Allergy Clin Immunol 2001;107:211-218.
42. 2 muscarinic receptor function. Am J Physiol 1997;273:L93-L103.